GENE ONLINE|News &
Opinion
Blog

2021-06-02| In-depthInterviews

The Maturation of Blood-Based Diagnostics to Nip Cancers in the Bud: An Interview with Dr. Jimmy Lin

by Rajaneesh K. Gopinath
Share To
The war against cancer is far from over, but modern medicine has made significant progress in winning some critical battles. Thanks to the rise of new modalities, cancer diagnosis and treatment have seen practice-changing advances. Liquid biopsy, the latest entrant to precision oncology, enables the screening of cancer prevalence and detects multiple cancers with a single blood test. However, there is merit in choosing to tackle one cancer at a time using a multi-pronged approach, says Dr. Jimmy Lin, Chief Scientific Officer of Freenome.

It's free! Log in now to read

LATEST
Flagship-Backed ProFound Launches With $75 Million to Discover Human Proteins
2022-05-27
Janssen’s First Cell Therapy Gets Europe’s Approval for Multiple Myeloma
2022-05-27
Cell and Gene Therapy Landscape in Japan is Moving Beyond Oncology
2022-05-27
New Study Reveals Hope for Recovery of Patients with Spinal Cord Injury
2022-05-27
Laekna Therapeutics Announces Dosing of First Patients in the U.S. and China in Phase Ib/III Study of Afuresertib in Combination with Fulvestrant in HR+/HER2- Breast Cancer
2022-05-26
Stanford Touts Remote-Controllable CAR-T Cell Therapy
2022-05-26
Phenomix Launches The First Obesity Biobank Registry To Study Underling Phenotypes
2022-05-26
EVENT
2022-06-03
ASCO Annual Meeting
Online and on-side
2022-06-07
Digital RESI June
Online
2022-06-09
Medhospafrica
Africa
2022-06-13
BIO International Convention
San Diego, CA
2022-12-14
BIOHK2022
Hong Kong, China
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!